Literature DB >> 19630535

Sequence polymorphisms provide a common consensus sequence for GPR41 and GPR42.

Chen W Liaw1, Daniel T Connolly.   

Abstract

GPR41 and GPR42 are two closely related genes that are part of a cluster of four adjacent G protein-coupled receptors (GPCRs) (GPR40, 41, 42, and 43) localized on human chromosome 19. There are only six nucleotide and amino acid differences between GPR41 and GPR42. High sequence homology between these two genes suggests that they are the result of a recent duplication event. Mutagenesis studies have previously shown that amino acid 174 is important for functional signaling since conversion of R174 (found in GPR41) to W174 (found in GPR42) silences the response to short chain fatty acids, raising the possibility that GPR42 might be an inactive pseudogene. In the present study, we present evidence showing that the six amino acid differences, including that R/W174 are polymorphisms rather than gene-specific differences between GPR41 and GPR42. Most importantly, of the 202 GPR42 alleles that were genotyped, 123 (61%) had arginine at amino acid 174, suggesting that GPR42 could potentially be a functional gene in a significant fraction of the human population and should therefore not be categorically characterized as an inactive pseudogene. In addition, a second copy of GPR40 was found to localize between GPR41 and GPR42 genes in human and chimp, suggesting that the duplication event that generated GPR42 in human and chimp might have involved a 12.5 kb DNA fragment that also contains GPR40. This second copy of the GPR40 gene is a pseudogene since it has diverged extensively from GPR40 and does not contain an open reading frame.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19630535     DOI: 10.1089/dna.2009.0916

Source DB:  PubMed          Journal:  DNA Cell Biol        ISSN: 1044-5498            Impact factor:   3.311


  12 in total

Review 1.  International Union of Basic and Clinical Pharmacology. LXXIX. Cannabinoid receptors and their ligands: beyond CB₁ and CB₂.

Authors:  R G Pertwee; A C Howlett; M E Abood; S P H Alexander; V Di Marzo; M R Elphick; P J Greasley; H S Hansen; G Kunos; K Mackie; R Mechoulam; R A Ross
Journal:  Pharmacol Rev       Date:  2010-12       Impact factor: 25.468

Review 2.  Microbial Short-Chain Fatty Acids and Blood Pressure Regulation.

Authors:  Jennifer L Pluznick
Journal:  Curr Hypertens Rep       Date:  2017-04       Impact factor: 5.369

3.  The Concise Guide to PHARMACOLOGY 2013/14: G protein-coupled receptors.

Authors:  Stephen P H Alexander; Helen E Benson; Elena Faccenda; Adam J Pawson; Joanna L Sharman; Michael Spedding; John A Peters; Anthony J Harmar
Journal:  Br J Pharmacol       Date:  2013-12       Impact factor: 8.739

Review 4.  Short chain fatty acids and methylamines produced by gut microbiota as mediators and markers in the circulatory system.

Authors:  Maksymilian Onyszkiewicz; Kinga Jaworska; Marcin Ufnal
Journal:  Exp Biol Med (Maywood)       Date:  2020-01-16

5.  Fatty acid binding receptors in intestinal physiology and pathophysiology.

Authors:  Elke Kaemmerer; Patrick Plum; Christina Klaus; Ralf Weiskirchen; Christian Liedtke; Maximilian Adolf; Angela Schippers; Norbert Wagner; Andrea Reinartz; Nikolaus Gassler
Journal:  World J Gastrointest Pathophysiol       Date:  2010-12-15

Review 6.  From microbe to man: the role of microbial short chain fatty acid metabolites in host cell biology.

Authors:  Niranjana Natarajan; Jennifer L Pluznick
Journal:  Am J Physiol Cell Physiol       Date:  2014-10-01       Impact factor: 4.249

Review 7.  Agonism and allosterism: the pharmacology of the free fatty acid receptors FFA2 and FFA3.

Authors:  Graeme Milligan; Leigh A Stoddart; Nicola J Smith
Journal:  Br J Pharmacol       Date:  2009-09       Impact factor: 8.739

Review 8.  International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands.

Authors:  Anthony P Davenport; Stephen P H Alexander; Joanna L Sharman; Adam J Pawson; Helen E Benson; Amy E Monaghan; Wen Chiy Liew; Chidochangu P Mpamhanga; Tom I Bonner; Richard R Neubig; Jean Philippe Pin; Michael Spedding; Anthony J Harmar
Journal:  Pharmacol Rev       Date:  2013-05-17       Impact factor: 25.468

9.  Short-chain free fatty acid receptors FFA2/GPR43 and FFA3/GPR41 as new potential therapeutic targets.

Authors:  Trond Ulven
Journal:  Front Endocrinol (Lausanne)       Date:  2012-10-02       Impact factor: 5.555

10.  Human GPR42 is a transcribed multisite variant that exhibits copy number polymorphism and is functional when heterologously expressed.

Authors:  Henry L Puhl; Yu-Jin Won; Van B Lu; Stephen R Ikeda
Journal:  Sci Rep       Date:  2015-08-11       Impact factor: 4.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.